Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

ClinicalTrials.gov ID: NCT00138762

Public ClinicalTrials.gov record NCT00138762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 11:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study of the Efficacy, Safety and Tolerability of Fixed Combination Torcetrapib/Atorvastatin Administered Orally Once Daily for 6 Months, Compared to Atorvastatin Alone or Placebo in Subjects With Mixed Dyslipidemia (Fredrickson Types IIa and IIb).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. A study to look at lipid levels in subjects taking the study drug, Atorvastatin alone or placebo.

Study identification

NCT ID
NCT00138762
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
3,800 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2004 (Type not available)
Primary completion
Aug 2006 (Actual)
Completion
Aug 2006 (Actual)
Last update posted
Feb 17, 2012

2004 – 2006

United States locations

U.S. sites
96
U.S. states
33
U.S. cities
96
Facility City State ZIP Site status
Pfizer Investigational Site Mobile Alabama — —
Pfizer Investigational Site Mesa Arizona — —
Pfizer Investigational Site Oro Valley Arizona — —
Pfizer Investigational Site Phoenix Arizona — —
Pfizer Investigational Site Sun City Arizona — —
Pfizer Investigational Site Little Rock Arkansas — —
Pfizer Investigational Site Anaheim California — —
Pfizer Investigational Site Carmichael California — —
Pfizer Investigational Site Concord California — —
Pfizer Investigational Site Greenbrae California — —
Pfizer Investigational Site Los Angeles California — —
Pfizer Investigational Site Mission Viejo California — —
Pfizer Investigational Site Sacramento California — —
Pfizer Investigational Site Santa Ana California — —
Pfizer Investigational Site Stockton California — —
Pfizer Investigational Site Thouasand Oaks California — —
Pfizer Investigational Site Tustin California — —
Pfizer Investigational Site Upland California — —
Pfizer Investigational Site Walnut Creek California — —
Pfizer Investigational Site Westlake Village California — —
Pfizer Investigational Site Boulder Colorado — —
Pfizer Investigational Site Waterbury Connecticut — —
Pfizer Investigational Site Newark Delaware — —
Pfizer Investigational Site Coral Gables Florida — —
Pfizer Investigational Site Ft. Pierce Florida — —
Pfizer Investigational Site Jacksonville Florida — —
Pfizer Investigational Site Jupiter Florida — —
Pfizer Investigational Site Lake Worth Florida — —
Pfizer Investigational Site Melbourne Florida — —
Pfizer Investigational Site Palm Bay Florida — —
Pfizer Investigational Site Sebastian Florida — —
Pfizer Investigational Site Stuart Florida — —
Pfizer Investigational Site Vero Beach Florida — —
Pfizer Investigational Site Wellington Florida — —
Pfizer Investigational Site West Palm Beach Florida — —
Pfizer Investigational Site Chicago Illinois — —
Pfizer Investigational Site Creve Coevr Illinois — —
Pfizer Investigational Site Peoria Illinois — —
Pfizer Investigational Site Rockford Illinois — —
Pfizer Investigational Site Iowa City Iowa — —
Pfizer Investigational Site Kansas City Kansas — —
Pfizer Investigational Site Overland Park Kansas — —
Pfizer Investigational Site Wichita Kansas — —
Pfizer Investigational Site Erlanger Kentucky — —
Pfizer Investigational Site Louisville Kentucky — —
Pfizer Investigational Site Covington Louisiana — —
Pfizer Investigational Site Slidell Louisiana — —
Pfizer Investigational Site Scarborough Maine — —
Pfizer Investigational Site Baltimore Maryland — —
Pfizer Investigational Site Bethesda Maryland — —
Pfizer Investigational Site Elkton Maryland — —
Pfizer Investigational Site Jackson Mississippi — —
Pfizer Investigational Site Jefferson City Missouri — —
Pfizer Investigational Site Kansas City Missouri — —
Pfizer Investigational Site Billings Montana — —
Pfizer Investigational Site Lincoln Nebraska — —
Pfizer Investigational Site Omaha Nebraska — —
Pfizer Investigational Site Las Vegas Nevada — —
Pfizer Investigational Site Endwell New York — —
Pfizer Investigational Site Lake Success New York — —
Pfizer Investigational Site Rochester New York — —
Pfizer Investigational Site Williamsville New York — —
Pfizer Investigational Site Charlotte North Carolina — —
Pfizer Investigational Site Concord North Carolina — —
Pfizer Investigational Site Fayetteville North Carolina — —
Pfizer Investigational Site Monroe North Carolina — —
Pfizer Investigational Site Raleigh North Carolina — —
Pfizer Investigational Site Winston-Salem North Carolina — —
Pfizer Investigational Site Cincinnati Ohio — —
Pfizer Investigational Site Elyria Ohio — —
Pfizer Investigational Site Olmsted Ohio — —
Pfizer Investigational Site Westlake Ohio — —
Pfizer Investigational Site Tulsa Oklahoma — —
Pfizer Investigational Site Beaverton Oregon — —
Pfizer Investigational Site Hillsboro Oregon — —
Pfizer Investigational Site Portland Oregon — —
Pfizer Investigational Site Warwick Rhode Island — —
Pfizer Investigational Site Greer South Carolina — —
Pfizer Investigational Site Spartanburg South Carolina — —
Pfizer Investigational Site Kingsport Tennessee — —
Pfizer Investigational Site Nashville Tennessee — —
Pfizer Investigational Site Austin Texas — —
Pfizer Investigational Site Beaumont Texas — —
Pfizer Investigational Site Bryan Texas — —
Pfizer Investigational Site Dallas Texas — —
Pfizer Investigational Site Houston Texas — —
Pfizer Investigational Site San Antonio Texas — —
Pfizer Investigational Site The Colony Texas — —
Pfizer Investigational Site Salt Lake City Utah — —
Pfizer Investigational Site Newport News Virginia — —
Pfizer Investigational Site Norfolk Virginia — —
Pfizer Investigational Site Richmond Virginia — —
Pfizer Investigational Site Renton Washington — —
Pfizer Investigational Site Yakima Washington — —
Pfizer Investigational Site Milwaukee Wisconsin — —
Pfizer Investigational Site Oregon Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00138762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2012 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00138762 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →